Aqua vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Alternative investment operations platform digitizing subscription and transfer workflows for Blackstone, Apollo, and Blue Owl; $2.6M YC-backed targeting $5B in transactions for 2025.
About
Aqua is a New York-based fintech platform providing operating system infrastructure for alternative investments — enabling asset managers, registered investment advisors (RIAs), broker-dealers, and financial advisors to process private equity, hedge fund, real estate, and other alternative asset subscriptions, transfers, and reporting through a unified digital workflow that replaces paper-heavy manual processes. Founded in 2021 and backed by Y Combinator with $2.6 million raised, Aqua serves major asset managers including Blackstone, Apollo Global Management, JLL, and Blue Owl Capital with 34 employees and $1.4 million in 2024 revenue.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.